58 related articles for article (PubMed ID: 25950896)
1. ASCCP Practice Guidelines Management Guidelines for the Follow-up of Atypical Squamous Cells of Undetermined Significance (ASCUS).
Cox TJ; Wilkinson EJ; Lonky N; Waxman A; Tosh R; Tedeschi C
J Low Genit Tract Dis; 2000 Apr; 4(2):99-105. PubMed ID: 25950896
[TBL] [Abstract][Full Text] [Related]
2. Participants at the ASCCP 2000 Biennial Meeting adhere to published guidelines in their management of atypical squamous cells and atypical glandular cells on pap test.
Ancheta E; Perry J; Bernard-Pearl L; Paul S; Darragh T; Smith-McCune K
J Low Genit Tract Dis; 2003 Oct; 7(4):279-84. PubMed ID: 17051084
[TBL] [Abstract][Full Text] [Related]
3. Hybrid Capture Human Papillomavirus Testing as an Adjunct to the Follow-Up of Patients with ASCUS and LGSIL Pap Smears: A Study of a Screening Population.
McLachlin CM; Alanen KW; Elit LM; Smith EA; Kerkvliet NA
J Low Genit Tract Dis; 2000 Jan; 4(1):12-7. PubMed ID: 25950784
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
Alanen KW; Elit LM; Molinaro PA; McLachlin CM
Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
[TBL] [Abstract][Full Text] [Related]
5. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
Layfield LJ; Qureshi MN
Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
[TBL] [Abstract][Full Text] [Related]
6. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
7. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
8. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
9. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
Toll AD; Kelly D; Maleki Z
Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
[TBL] [Abstract][Full Text] [Related]
10. Management of women with atypical Papanicolaou tests of undetermined significance by board-certified gynecologists: discrepancies with published guidelines.
Smith-McCune K; Mancuso V; Contant T; Jackson R
Am J Obstet Gynecol; 2001 Sep; 185(3):551-6. PubMed ID: 11568776
[TBL] [Abstract][Full Text] [Related]
11. Atypical squamous and glandular cells of undetermined significance (ASCUS and AGUS) of the uterine cervix.
Cenci M; Vecchione A
Anticancer Res; 2000; 20(5C):3701-7. PubMed ID: 11268442
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
13. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion.
Gonzalez D; Hernandez E; Anderson L; Heller P; Atkinson BF
J Reprod Med; 1996 Oct; 41(10):719-23. PubMed ID: 9026557
[TBL] [Abstract][Full Text] [Related]
15. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
16. Resolving ASCUS without recourse to HPV testing: manual reprocessing of residual automated liquid-based cytology (ALBC) material using manual liquid-based cytology (MLBC).
Maksem JA; Bedrossian CW; Kurtycz D; Sewall S; Shalkham J; Dhanwada V; Lind H; Bibbo M; Weidmann J; Kane B; Shi Fu Y
Diagn Cytopathol; 2005 Dec; 33(6):434-40. PubMed ID: 16299747
[TBL] [Abstract][Full Text] [Related]
17. Atypical squamous cells of undetermined significance qualified: a follow-up study.
Kline MJ; Davey DD
Diagn Cytopathol; 1996 Jun; 14(4):380-4. PubMed ID: 8725142
[TBL] [Abstract][Full Text] [Related]
18. Predictors of follow-up of atypical and ASCUS papanicolaou tests in a high-risk population.
McKee MD; Schechter C; Burton W; Mulvihill M
J Fam Pract; 2001 Jul; 50(7):609. PubMed ID: 11485710
[TBL] [Abstract][Full Text] [Related]
19. Atypical squamous cells of undetermined significance. Current laboratory practices of participants in the College of American Pathologists Interlaboratory. Comparison Program in Cervicovaginal Cytology.
Davey DD; Nielsen ML; Naryshkin S; Robb JA; Cohen T; Kline TS
Arch Pathol Lab Med; 1996 May; 120(5):440-4. PubMed ID: 8639046
[TBL] [Abstract][Full Text] [Related]
20. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
